Literature DB >> 23522741

Current options for the treatment of facial angiofibromas.

R Salido-Vallejo1, G Garnacho-Saucedo2, J C Moreno-Giménez2.   

Abstract

Facial angiofibromas are hamartomatous growths that are closely associated with tuberous sclerosis complex and, in fact, they constitute one of the main diagnostic criteria for that disease. These lesions composed of blood vessels and fibrous tissue appear on the face at an early age. Since they have important physical and psychological repercussions for patients, several treatment options have been used to remove them or improve their appearance. However, the lack of treatment guidelines prevents us from developing a common protocol for patients with this condition. The present article aims to review the treatments for facial angiofibromas used to date and to propose a new evidence-based treatment protocol.
Copyright © 2012 Elsevier España, S.L. and AEDV. All rights reserved.

Entities:  

Keywords:  Angiofibroma; Esclerosis tuberosa; Laser therapy; Sirolimus; Terapia láser; Terapéutica; Therapeutics; Tuberous sclerosis

Mesh:

Substances:

Year:  2013        PMID: 23522741     DOI: 10.1016/j.ad.2012.11.020

Source DB:  PubMed          Journal:  Actas Dermosifiliogr        ISSN: 0001-7310


  5 in total

1.  Sirolimus-Associated Pruritus: Case Report and Review.

Authors:  Joyce Y Cheng; Philip R Cohen
Journal:  Cureus       Date:  2017-06-27

Review 2.  Efficacy and Safety of Topical Mechanistic Target of Rapamycin Inhibitors for Facial Angiofibromas in Patients with Tuberous Sclerosis Complex: A Systematic Review and Network Meta-Analysis.

Authors:  Yu-Ting Lin; Chia-Ling Yu; Yu-Kang Tu; Ching-Chi Chi
Journal:  Biomedicines       Date:  2022-03-31

3.  Impact of facial angiofibromas in tuberous sclerosis complex and reported efficacy of available treatments.

Authors:  Marie Monaghan; Pooja Takhar; Luke Langlands; Markus Knuf; Sam Amin
Journal:  Front Med (Lausanne)       Date:  2022-08-29

4.  Characterization and management of facial angiofibroma related to tuberous sclerosis complex in the United States: retrospective analysis of the natural history database.

Authors:  Sreedevi Boggarapu; Steven L Roberds; JoAnne Nakagawa; Eric Beresford
Journal:  Orphanet J Rare Dis       Date:  2022-09-14       Impact factor: 4.303

5.  Mixed Polymeric Micelles for Rapamycin Skin Delivery.

Authors:  Guillaume Le Guyader; Bernard Do; Ivo B Rietveld; Pascale Coric; Serge Bouaziz; Jean-Michel Guigner; Philippe-Henri Secretan; Karine Andrieux; Muriel Paul
Journal:  Pharmaceutics       Date:  2022-03-04       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.